FCMAX
Price
$12.36
Change
-$0.00 (-0.00%)
Updated
Jun 12 closing price
Net Assets
1.87B
TECCX
Price
$16.82
Change
-$0.00 (-0.00%)
Updated
Jun 12 closing price
Net Assets
3.67B
Interact to see
Advertisement

FCMAX vs TECCX

Header iconFCMAX vs TECCX Comparison
Open Charts FCMAX vs TECCXBanner chart's image
FCMAX vs TECCX Comparison Chart in %
View a ticker or compare two or three
VS
FCMAX vs. TECCX commentary
Jun 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FCMAX is a Hold and TECCX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
TECCX has more cash in the bank: 3.67B vs. FCMAX (1.87B). FCMAX pays higher dividends than TECCX: FCMAX (2.70) vs TECCX (2.30). FCMAX was incepted earlier than TECCX: FCMAX (24 years) vs TECCX (25 years). TECCX (1.31) is less costly to investors than FCMAX (0.76). TECCX is a more actively managed with annual turnover of: 32.00 vs. FCMAX (19.00). FCMAX has a lower initial minimum investment than TECCX: FCMAX (0) vs TECCX (1000). FCMAX annual gain was more profitable for investors over the last year : 6.56 vs. TECCX (3.51). FCMAX return over 5 years is better than : 2.99 vs. TECCX (-8.67).
FCMAXTECCXFCMAX / TECCX
Total Expense Ratio0.761.3158%
Annual Report Gross Expense Ratio0.761.3158%
Fund Existence24 years25 years-
Gain YTD0.9620.119808%
Front Load4%N/A-
Min. Initial Investment01000-
Min. Initial Investment IRAN/AN/A-
Net Assets1.87B3.67B51%
Annual Yield % from dividends2.702.30117%
Returns for 1 year6.563.51187%
Returns for 3 years11.663.35348%
Returns for 5 years2.99-8.67-34%
Returns for 10 years17.00-5.28-322%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VSME1.690.58
+52.25%
VS Media Holdings Limited
PENN21.680.47
+2.22%
PENN Entertainment
NRIM25.800.28
+1.10%
Northrim BanCorp
BEN32.130.32
+1.01%
Franklin Resources
PTHS27.50-1.22
-4.25%
Pelthos Therapeutics Inc